Eliminating hepatitis C among people who use drugs: The latest research and its implications for the front lines

Event Date: 
30 October 2018, 16:00 EDT

A webinar in partnership with the International Network on Hepatitis in Substance Users

Eliminating hepatitis C is possible through scaling up testing efforts, offering highly effective treatments that cure almost everyone, and preventing new infections through comprehensive harm reduction services. Injection drug use is the most common way a person acquires hepatitis C in Canada. However, people who use drugs experience barriers to accessing safe and appropriate health services.

Join us for a spotlight on key discussions and findings from the International Network on Hepatitis in Substance Users (INHSU) 2018 conference and the HEP-C Community Summit, taking place in Portugal this year.

This webinar will highlight important international issues and new research with a focus on needs, gaps and opportunities to eliminate hepatitis C among people who use drugs, and will discuss the relevance of international programming, policy and research for frontline practice in Canada.

Moderator: Christopher Hoy, Knowledge Specialist, Hepatitis C Community Health Programming, CATIE

Speakers:

  • Jason Grebely, President, International Network on Hepatitis in Substance Users
  • Rivka Kushner, Knowledge Specialist, Hepatitis C, CATIE
  • Jennifer Broad, Community Support Worker, South Riverdale Community Health Centre 
  • Keith Williams, Community Support Worker, South Riverdale Community Health Centre
  • Tamara Barnett, Registered Nurse and HCV Program Coordinator, Cool Aid Community Health Centre

A French version of this webinar will take place on November 13, from 1:00 to 2:30 p.m.

Powerpoint/PDF File: